Search Results - Winald R. Gerritsen
- Showing 1 - 20 results of 55
- Go to Next Page
-
1
The evolving role of immunotherapy in prostate cancer by Winald R. Gerritsen
Published 2012Revisão -
2
-
3
-
4
-
5
-
6
Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters by Carlijn Voermans, Winald R. Gerritsen, A. E. G. Kr. von dem Borne, C. Ellen van der Schoot
Published 1999Artigo -
7
Implementing physical activity programs for patients with cancer in current practice: patients’ experienced barriers and facilitators by Charlotte IJsbrandy, Rosella Hermens, Laura W. M. Boerboom, Winald R. Gerritsen, Wim H. van Harten, Petronella B. Ottevanger
Published 2019Artigo -
8
-
9
-
10
-
11
-
12
Therapeutic vaccines for cancer: an overview of clinical trials by Ignacio Melero, Gustav Gaudernack, Winald R. Gerritsen, Christoph Huber, Giorgio Parmiani, Suzy Scholl, Nicholas Thatcher, John Wagstaff, Christoph Zielinski, Ian Faulkner, Håkan Mellstedt
Published 2014Revisão -
13
Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins by Iris S. Weimar, Daphne de Jong, E J Muller, Toshikazu Nakamura, Joost M. H. H. van Gorp, Gijsbert C. de Gast, Winald R. Gerritsen
Published 1997Artigo -
14
-
15
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts by Birgit Geoerger, Jacques Grill, Paule Opolon, Jackie Morizet, Geneviève Aubert, Yann Lécluse, Victor W. van Beusechem, Winald R. Gerritsen, David H. Kirn, Gilles Vassal
Published 2003Artigo -
16
Maturation of Dendritic Cells Accompanies High-Efficiency Gene Transfer by a CD40-Targeted Adenoviral Vector by Bryan Tillman, Tanja D. de Gruijl, Sylvia A. Luykx‐de Bakker, Rik J. Scheper, Herbert M. Pinedo, Tyler J. Curiel, Winald R. Gerritsen, David T. Curiel
Published 1999Artigo -
17
-
18
-
19
Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM by Hidde J. Haisma, Herbert M. Pinedo, A. Van Rijswijk, Ida Van der Meulen-Muileman, Barbara A. Sosnowski, Wenbin Ying, Victor W. van Beusechem, Bryan Tillman, Winald R. Gerritsen, DT Curiel
Published 1999Artigo -
20
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide by Guillemette E. Benoist, Rianne J. Hendriks, Peter F.A. Mulders, Winald R. Gerritsen, Diederik M. Somford, Jack A. Schalken, Inge M. van Oort, David M. Burger, Nielka P. van Erp
Published 2016Revisão
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Immunology
Cancer research
Immunotherapy
Prostate cancer
Biology
Immune system
Biochemistry
Chemotherapy
Docetaxel
Urology
Antigen
Clinical trial
Genetics
Ipilimumab
Melanoma
Vaccination
Adverse effect
Androgen deprivation therapy
Gene
In vitro
Pathology
Pharmacology
Randomized controlled trial
CD8
Cancer immunotherapy
Cell biology